Concerta ER 54 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F56ME
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,989
Award facts
- Contract value 100% obligated
- $48,988.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) with a ceiling value of $48,988.56. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen's extensive portfolio of federal medical supply contracts demonstrates its established capability to deliver pharmaceutical products across multiple therapeutic domains to support military healthcare systems. The company's DLA IDC serves as a comprehensive vehicle enabling supply of medications, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide. This delivery order for Concerta ER tablets, a controlled-release methylphenidate medication commonly used for attention deficit hyperactivity disorder treatment, represents a routine fulfillment of the vendor's obligations under its prime indefinite delivery contract with the federal government's primary defense logistics procurement agency.
Quick answers
Who was awarded contract SPE2DR26F56ME?
SPE2DR26F56ME was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F56ME worth?
The government has obligated $48,989 on SPE2DR26F56ME.
Is contract SPE2DR26F56ME an order under another contract?
Yes. SPE2DR26F56ME is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F56ME competed?
The extent of competition for SPE2DR26F56ME was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award